期刊文献+

从随意性联合治疗到个体化联合治疗——对当前恶性肿瘤治疗规范化困境的思考 被引量:1

From Arbitrary Combination Therapy to Individualized Combination Therapy-Considerations on Dilemma of Present Standardization Treatment of Malignant Tumors
下载PDF
导出
摘要 通过分析当前"随意性联合治疗"的原因,提出恶性肿瘤"个体化联合治疗"的概念和工作模式,并从"创新管理模式、落实临床指南、制定技术规范、学科标准建设、专科医师培养、统一科普宣教"等6个方面阐述其形成条件。面向服务对象的单病种人机对话专家系统的研制和应用,有助于克服临床决策中各种人为因素的干扰,有利于将优势技术真正转化为患者的临床获益,促进和保障恶性肿瘤"个体化联合治疗"的临床实践。 The causes of arbitrary combination therapy for malignant tumors are analyzed,and the concept and working mode of individualized combination therapy are put forward.Furthermore,the shaping conditions of the individualized combination therapy are expatiated upon in the following aspects: innovation management mode,implementation of clinical guidelines,technical regulations development,standard construction of the discipline,specialist training in oncology,unified popular science education.A client-oriented human-machine conversation expert system for single disease is developed and utilized,which overcomes the influence of various personal factors on clinical decision-making,helps to translate the advantage technology into clinical benefits for patients truly,and promotes and ensures clinical implementation of the individualized combination therapy.
机构地区 解放军
出处 《医疗卫生装备》 CAS 2011年第10期96-98,共3页 Chinese Medical Equipment Journal
关键词 恶性肿瘤 个体化联合治疗 循证医学 人机对话专家系统 临床获益 malignant tumors individualized combination therapy evidence-based medicine human-machine conversation expert system clinical benefits
  • 相关文献

参考文献7

  • 1刘泰福.中国放射肿瘤学的过去、未来和现在[J].中华放射肿瘤学杂志,2006,15(5):355-358. 被引量:4
  • 2李前文 杜云翔 山顺林.放射治疗科规范化建设与管理概述.医疗卫生装备,2010,:268-230. 被引量:1
  • 3孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生社出版.2007.152. 被引量:303
  • 4吴一龙.恶性肿瘤多学科综合治疗的困境[J].循证医学,2008,8(1):1-2. 被引量:45
  • 5Stewart L A,Burdett S,Tierney J F,et al. On behalf of the NSCLC Collaborative Group. Surgery and adjuvant chemotherapy (CT) compared to surgery alone in non-small cell lung cancer(NSCLC) :A meta-analysis using individual patient data (IPD) from randomized clinical trials (RCT)[J]. J C lin Oncol, 2007,25 (18S) :7 552. 被引量:1
  • 6中华医学会编著..临床诊疗指南 肿瘤分册[M].北京:人民卫生出版社,2005:708.
  • 7杜云翔,李前文主编..规范化放射治疗工作流程[M].北京:人民军医出版社,2009:115.

二级参考文献5

  • 1Bulzebruck H,Bopp R,Drings P,et al.New aspects in the staging of lung cancer.Prospective validation of the International Union Against Cancer TNM classification[J].Cancer,1992,70:1102-1110. 被引量:1
  • 2Fry WA,Menck HR,Winchester DP.The national cancer data base report on lung cancer[J].Cancer,1996,77:1947-1955. 被引量:1
  • 3Sugimura H, Nichols FC,Yang P,et al1.Survival after recurrent non-small-cell lung cancer after complete pulmonary resection[J].Ann Thorac Surg,2007,83:409-418. 被引量:1
  • 4Stewart LA,Burdett S,Tierney JF,et al.On behalf of the NSCLC Collaborative Group,Surgery and adjuvant chemotherapy(CT)compared to surgery alone in non-small cell lung cancer(NSCLC):A meta-analysis using individual patient data(IPD) from randomized clinical trials(RCT)[J].J Clin Oncol,2007 ASCO Annual Meeting Proceedings Part Ⅰ,2007,25(18S):7552 被引量:1
  • 5Potosky AL, Saxman S, Wallace RB, et al,Population variations in the initial treatment of non-small-cell lung cancer [J].J Clin Oncol,2004,22:3261-3268. 被引量:1

共引文献349

同被引文献5

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部